From: Safety and efficacy of directly acting antivirals (sofosbuvir and daclatasvir) in treatment of chronic HCV in HIV-HCV co-infected Egyptian patients
Items
CD4 lymphocytic count (mean ± SD)
Before treatment
310.60 ±89.9
End of treatment
385.90 ±108.71
SVR at 12 weeks
445.13 ±125.44
F-value
11.482
P-value
0.0001
Significance
S